Is The Gain Worth The Pain?
By: Sandra K. Rodriguez, Market Analyst
Pharmaceutical organizations are continuously seeking to implement mature manufacturing technologies to ensure the availability of products for their patients. Unfortunately, once a facility has been approved for manufacturing by regulators, it is often frozen in time for decades. This has been one of the unintended consequences of regulatory enforcement and has led to the slow uptake of modernization and digital transformation in Pharma.
Pharmaceutical business models are changing, and supply chains have become tightly integrated supply networks. In addition, regulatory agencies, although often seen as the industry’s biggest business disruptori, are actually encouraging innovation in manufacturing. Life-Science companies are cloud curious and most are in the pilot phase of implementing emerging technologies such as Artificial Intelligence (AI), Machine Learning (ML), Augmented Reality (AR) and Virtual Reality (VR).
Based on Axendia’s primary research and interviews with executives on the adoption of modernization and digital transformation in the Life-Science industry, we determined that digital transformation and modernizing manufacturing often do not go hand in hand. In fact, through our discussions and interactions with industry executives for this report, we quickly determined that digital transformation and modernizing manufacturing are not synonymous and often take different paths.Continue reading